Abingworth Co-Investors 2026

Abingworth accounts for 31 tracked companies with verified cap-table data, 31 of which disclose round sizes totalling $7.1B. The median disclosed raise is $120M, and the largest is Vaxcyte at $2.4B, ahead of Tubulis ($575M) and AdvanCell ($440M).

The names that recur most often on these co-invested cap tables are Abingworth (31 companies), Osage University Partners (5 companies), Atlas Venture (5 companies), 4BIO Capital (4 companies), Surveyor Capital (4 companies), Omega Funds (4 companies). By latest disclosed round, the market skews Series A (15), Series B (7), Series C (2), IPO (1).

• Companies tracked: 31
• Disclosed funding total: $7.1B across 31 companies
• Median disclosed raise: $120M
• Largest raise: Vaxcyte — $2.4B
• Stage mix: Series A 15 · Series B 7 · Series C 2 · IPO 1
• Most recent dated round: 2026-05-20

Best funded Abingworth companies

1. Vaxcyte — $2.4B (latest: IPO)
2. Tubulis — $575M (latest: Series A)
3. AdvanCell — $440M (latest: Series D)
4. Gynesonics — $338M (latest: Series F)
5. Effector Therapeutics — $325M (latest: Series A)
6. GenSight Biologics — $264M
7. Escient Pharmaceuticals — $238M (latest: Series C)
8. Attralus — $201M (latest: Series B)
9. Wugen — $200M (latest: Series B)
10. cAMPfield Therapeutics — $180M (latest: Series A)
11. Timberlyne Therapeutics — $180M (latest: Series A)
12. Antares Therapeutics — $177M (latest: Series A)
13. Chiasma — $161M
14. Ascend — $130M (latest: Series A)
15. Ascend Advanced Therapies — $130M (latest: Series A)

Abingworth — related firms and companies (56)

• Vaxcyte
• Tubulis
• AdvanCell
• Gynesonics
• Effector Therapeutics
• GenSight Biologics
• Escient Pharmaceuticals
• Attralus
• Avila Therapeutics
• Investors like Ventioneers
• Investors like Bond
• Ascend
• Investors like Salesforce Ventures
• Reneo Pharmaceuticals
• Investors like Irving Investors
• Q32 Bio
• Investors like CAVU Consumer Partners
• Abingworth portfolio companies 2026
• Wugen
• Investors like Alexandria Venture Investments
• Ascend Advanced Therapies
• Investors like Motivate Venture Capital
• Cytospire Therapeutics
• Investors like Fika Ventures
• Anjarium Biosciences
• Investors like Digital Currency Group
• Investors like Abingworth
• cAMPfield Therapeutics
• Investors like Torch Capital
• Solve Therapeutics
• Investors like Service Provider Capital
• Entact Bio
• Investors like AME Cloud Ventures
• IFM Therapeutics
• Investors like Madrona
• Companies backed by Abingworth
• Timberlyne Therapeutics
• Investors like Meritech Capital Partners
• Myricx Bio
• Investors like General Atlantic
• R1 Therapeutics
• Investors like Upfront Ventures
• Venatorx Pharmaceuticals, Inc.
• Investors like Norwest Venture Partners
• Founders backed by Abingworth
• Antares Therapeutics
• Investors like Slow Ventures
• Nido Biosciences
• Investors like Felicis
• Personalis
• Investors like Insight Partners
• Pixium Vision
• Investors like Bessemer Venture Partners
• Investors like Kleiner Perkins
• Chiasma
• Investors like Sequoia Capital

Abingworth profile · All research reports